198 related articles for article (PubMed ID: 22991413)
1. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients.
Sveen A; Ågesen TH; Nesbakken A; Meling GI; Rognum TO; Liestøl K; Skotheim RI; Lothe RA
Clin Cancer Res; 2012 Nov; 18(21):6001-10. PubMed ID: 22991413
[TBL] [Abstract][Full Text] [Related]
2. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
4. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.
Salazar R; Roepman P; Capella G; Moreno V; Simon I; Dreezen C; Lopez-Doriga A; Santos C; Marijnen C; Westerga J; Bruin S; Kerr D; Kuppen P; van de Velde C; Morreau H; Van Velthuysen L; Glas AM; Van't Veer LJ; Tollenaar R
J Clin Oncol; 2011 Jan; 29(1):17-24. PubMed ID: 21098318
[TBL] [Abstract][Full Text] [Related]
5. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
[TBL] [Abstract][Full Text] [Related]
9. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
10. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
[TBL] [Abstract][Full Text] [Related]
11. The DCC protein and prognosis in colorectal cancer.
Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
[TBL] [Abstract][Full Text] [Related]
12. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
13. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
14. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
15. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
Bertucci F; Borie N; Roche H; Bachelot T; Le Doussal JM; Macgrogan G; Debono S; Martinec A; Treilleux I; Finetti P; Esterni B; Extra JM; Geneve J; Hermitte F; Chabannon C; Jacquemier J; Martin AL; Longy M; Maraninchi D; Fert V; Birnbaum D; Viens P
Breast Cancer Res Treat; 2011 Jun; 127(2):363-73. PubMed ID: 20585850
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
19. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
20. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]